• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI 0.00% 1.1¢

ALGORAE PHARMACEUTICALS LIMITED - News & Media

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

No News & Media currently available.

(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $18.56M
Open High Low Value Volume
1.1¢ 1.1¢ 1.1¢ $22.16K 2.015M

Buyers (Bids)

No. Vol. Price($)
4 1396940 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 749091 7
View Market Depth
Last trade - 15.59pm 13/05/2024 (20 minute delay) ?
Last
1.1¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
1.2¢ 1.2¢ 1.1¢ 75000
Last updated 13.37pm 13/05/2024 ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.